Cannabinoid receptor CB2 is involved in tetrahydrocannabinol-induced anti-inflammation against lipopolysaccharide in MG-63 cells

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Yang, Lei ^a,b   Li, Fei Fei ^a   Han, Yu Chen ^a   Jia, Bin ^c   Ding, Yin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 264th Hospital of PLA   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 2 RECEPTOR; COFILIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR ALPHA; DRONABINOL; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; OSTEOARTHRITIS; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; DRONABINOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; RECEPTOR, CANNABINOID, CB2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947648665     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/362126     Document Type: Article

References (36)

1. R. Sun, B. Zhang, L. Chen, and J. Sun, "Role of nuclear factor of activated T cells 1 in the pathogenesis of osteoarthritis, " Experimental and TherapeuticMedicine, vol. 7, no. 1, pp. 195-198, 2013.
2. X. Liu, Y. Xu, S. Chen et al., "Rescue of proinflammatory cytokine-inhibited chondrogenesis by the antiarthritic effect of melatonin in synovium mesenchymal stem cells via suppression of reactive oxygen species and matrix metalloproteinases, " Free Radical Biology and Medicine, vol. 68, pp. 234-246, 2014.
3. M. A. Karsdal, A. C. Bay-Jensen, R. J. Lories et al., "The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?, " Annals of the Rheumatic Diseases, vol. 73, no. 2, pp. 336-348, 2014.
4. S. Yang, C. E. Dubé, C. B. Eaton, T. E. McAlindon, and K. L. Lapane, "Longitudinal use of complementary and alternative medicine among older adults with radiographic knee osteoarthritis, " Clinical Therapeutics, vol. 35, no. 11, pp. 1690-1702, 2013.
5. Y. Tu, H. Xue, W. Francis et al., "Lactoferrin inhibits dexamethasone-induced chondrocyte impairment from osteoarthritic cartilage through up-regulation of extracellular signal-regulated kinase 1/2 and suppression of FASL, FAS, and Caspase 3, " Biochemical and Biophysical Research Communications, vol. 441, no. 1, pp. 249-255, 2013.
6. L. Gallelli, O. Galasso, D. Falcone et al., "The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial, " Osteoarthritis and Cartilage, vol. 21, no. 9, pp. 1400-1408, 2013.
7. A. Lanas, J. L. Goldstein, F. K. L. Chan et al., "Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR), " Alimentary Pharmacology andTherapeutics, vol. 36, no. 5, pp. 485-492, 2012.
8. R. Chen, J. Zhang, N. Fan et al., "δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling, " Cell, vol. 155, no. 5, pp. 1154-1165, 2013.
9. I. G. Otterness, M.-P. H. Le Graverand, and F. Eckstein, "Allometric relationships between knee cartilage volume, thickness, surface area and body dimensions, "Osteoarthritis and Cartilage, vol. 16, no. 1, pp. 34-40, 2008.
10. D. Kleinloog, J. Stevens, J. Heuberger, P. Spinhoven, and J. van Gerven, "The influence of personality on the sensitivity to subjective effects of δ9-tetrahydrocannabinol, " Psychiatry Research, vol. 220, no. 3, pp. 945-953, 2014.
11. W. B. Veldhuis, M. van der Stelt, M. W. Wadman et al., "Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases, " The Journal of Neuroscience, vol. 23, no. 10, pp. 4127-4133, 2003.
12. W. Wang, R. Eddy, and J. Condeelis, "The cofilin pathway in breast cancer invasion and metastasis, " Nature Reviews Cancer, vol. 7, no. 6, pp. 429-440, 2007.
13. W.-J. Ma, X. Guo, J.-T. Liu et al., "Proteomic changes in articular cartilage of human endemic osteoarthritis in China, " Proteomics, vol. 11, no. 14, pp. 2881-2890, 2011.
14. N. Chiang, J. M. Schwab, G. Fredman, K. Kasuga, S. Gelman, and C. N. Serhan, "Anesthetics impact the resolution of inflammation, " PLoS ONE, vol. 3, no. 4, Article ID e1879, 2008.
15. J. Rüegg, F. Holsboer, C. Turck, and T. Rein, "Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cells, "Molecular and Cellular Biology, vol. 24, no. 21, pp. 9371-9382, 2004.
16. F. Fazal, K. M. Bijli, M. Minhajuddin, T. Rein, J. N. Finkelstein, and A. Rahman, "Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells, " Journal of Biological Chemistry, vol. 284, no. 31, pp. 21047-21056, 2009.
17. M. M. Kim, E. Mendis, N. Rajapakse, and S.-K. Kim, "Glucosamine sulfate promotes osteoblastic differentiation of MG-63 cells via anti-inflammatory effect, " Bioorganic andMedicinal Chemistry Letters, vol. 17, no. 7, pp. 1938-1942, 2007.
18. X. Xu, J. A. Kim, and Z. Zuo, "Isoflurane preconditioning reduces mouse microglial activation and injury induced by lipopolysaccharide and interferon-gamma, " Neuroscience, vol. 154, no. 3, pp. 1002-1008, 2008.
19. T. H. Huang, Y. C. Lu, and C. T. Kao, "Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation, " Lasers in Medical Science, vol. 27, no. 3, pp. 621-627, 2012.
20. J. D. Leu, Y. W. Chiu, C. C. Lo et al., "Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity, " International Journal of Radiation Biology, vol. 89, no. 6, pp. 433-444, 2013.
21. Y.-J. Lee, T.-J. Sheu, and P. C. Keng, "Enhancement of radiosensitivity in H1299 cancer cells by actin-associated protein cofilin, " Biochemical and Biophysical Research Communications, vol. 335, no. 2, pp. 286-291, 2005.
22. S. Hashimoto, R. L. Ochs, S. Komiya, and M. Lotz, "Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis, " Arthritis andRheumatism-Arthritis Care andResearch, vol. 41, no. 9, pp. 1632-1638, 1998.
23. C. T. Hepper, J. J. Halvorson, S. T. Duncan, A. J. M. Gregory, W. R. Dunn, and K. P. Spindler, "The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies, " Journal of the American Academy of Orthopaedic Surgeons, vol. 17, no. 10, pp. 638-646, 2009.
24. L. Gallelli, O. Galasso, D. Falcone et al., "The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial, " Osteoarthritis and Cartilage, vol. 21, no. 9, pp. 1400-1408, 2013.
25. A. Pareek and N. Chandurkar, "Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis, " CurrentMedical Research andOpinion, vol. 29, no. 7, pp. 849-859, 2013.
26. D. Bolognini, B. Costa, S. Maione et al., "The plant cannabinoid δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice, " British Journal of Pharmacology, vol. 160, no. 3, pp. 677-687, 2010.
27. N. Egashira, N. Manome, K. Mishima, K. Iwasaki, R. Oishi, and M. Fujiwara, "Involvement of opioid systemin cognitive deficits induced by δ9-tetrahydrocannabinol in rats, " Psychopharmacology, vol. 219, no. 4, pp. 1111-1118, 2012.
28. Q. Li, H. C. Guo, L. N. Maslov, X. W. Qiao, J. J. Zhou, and Y. Zhang, "Mitochondrial permeability transition pore plays a role in the cardioprotection of CB2 receptor against ischemiareperfusion injury, " Canadian Journal of Physiology and Pharmacology, vol. 92, no. 3, pp. 205-214, 2014.
29. S. Locatelli-Hoops, F. C. Sheen, L. Zoubak, K. Gawrisch, and A. A. Yeliseev, "Application of HaloTag technology to expression and purification of cannabinoid receptor CB2, " Protein Expression and Purification, vol. 89, no. 1, pp. 62-72, 2013.
30. D. V. Gondim, J. C. B. Araujo, A. L. C. Cavalcante et al., "CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint, " Canadian Journal of Physiology and Pharmacology, vol. 90, no. 11, pp. 1479-1489, 2012.
31. J. G. Zarruk, D. Fernández-Lopez, I. García-Yébenes et al., "Cannabinoid type 2 receptor activation downregulates strokeinduced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection, " Stroke, vol. 43, no. 1, pp. 211-219, 2012.
32. C. A. Newton and T. W. Klein, "Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice, " Journal of Neuroimmune Pharmacology, vol. 7, no. 3, pp. 591-598, 2012.
33. T. Kawano, M. Zhu, N. Troiano et al., "LIM kinase 1 deficient mice have reduced bone mass, " Bone, vol. 52, no. 1, pp. 70-82, 2013.
34. F. He and Z.-H. Song, "Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells, " Molecular Vision, vol. 13, pp. 1348-1356, 2007.
35. F. Weis, A. Beiras-Fernandez, D. Hauer et al., "Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery, " British Journal of Anaesthesia, vol. 105, no. 2, pp. 139-144, 2010.
36. S. Rom, V. Zuluaga-Ramirez, H. Dykstra, N. L. Reichenbach, P. Pacher, and Y. Persidsky, "Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier, " The American Journal of Pathology, vol. 183, no. 5, pp. 1548-1558, 2013.